Federal Register / Vol. 65, No. 106 / Thursday, June 1, 2000 / Notices 35103

amended (5 U.S.C. Appendix 2), notice

is hereby given to the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Nursing Research Special Emphasis Panel To

review Individual National Research Service

Award Applications.

Date: June 23, 2000.

Time: 1 PM to 4 PM.

Agenda: To review and evaluate grant

applications.

Place: Building 45, Room 3AN–18B, MD

20892 (Telephone Conference Call).

Contact Person: Mary J. Stephens-Frazier,

PHD, Scientific Review Administrator,

National Institute of Nursing Research,

National Institutes of Health, Natcher

Building, Room 3AN32, Bethesda, MD 20892,

(301) 594–5971.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.361, Nursing Research,

National Institutes of Health, HHS)

Dated: May 25, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–13719 Filed 5–31–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Neurological

Disorders and Stroke; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Neurological Disorders and Stroke Special

Emphasis Panel.

Date: June 1, 2000.

Time: 1 PM to 2 PM.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Phillip F. Wiethorn,

Scientific Review Administrator, Scientific

Review Branch, NINDS/NIH/DHHS,

Neuroscience Center, 6001 Executive Blvd.,

Suite 3208, MSC 9529, Bethesda, MD 20892–

9529, 301–496–9223.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute of

Neurological Disorders and Stroke Special

Emphasis Panel.

Date: June 28, 2000.

Time: 1 PM to 3 PM.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Phillip F. Wiethorn,

Scientific Review Administrator, Scientific

Review Branch, NINDS/NIH/DHHS,

Neuroscience Center, 6001 Executive Blvd.,

Suite 3208, MSC 9529, Bethesda, MD 20892–

9529, 301–496–9223.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.853, Clinical Research

Related to Neurological Disorders; 93.854,

Biological Basis Research in the

Neurosciences, National Institutes of Health,

HHS)

Dated: May 25, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–13720 Filed 5–31–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, Viral

Hepatitis and HIV in Drug and Alcohol

Users.

Date: July 27, 2000.

Time: 9:00 am to 6:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P

Street NW, Washington, DC 20037.

Contact Person: Kesinee Nimit, MD, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1432.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards, 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health,

HHS).

Dated: May 24, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–13725 Filed 5–31–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Aging; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Aging Specil Emphasis Panel, Molecular

Mechanisms of Signaling in Aging and AD.

Date: May 31–June 1, 2000.

Time: 7:00 pm to 4:30 pm.

Agenda: To review and evaluate grant

applications.